[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0618610A2 - derivados de pirrolidina como inibidores de fator xa de coagulação - Google Patents

derivados de pirrolidina como inibidores de fator xa de coagulação Download PDF

Info

Publication number
BRPI0618610A2
BRPI0618610A2 BRPI0618610-6A BRPI0618610A BRPI0618610A2 BR PI0618610 A2 BRPI0618610 A2 BR PI0618610A2 BR PI0618610 A BRPI0618610 A BR PI0618610A BR PI0618610 A2 BRPI0618610 A2 BR PI0618610A2
Authority
BR
Brazil
Prior art keywords
alkyl
optionally substituted
carbonyl
amino
oxo
Prior art date
Application number
BRPI0618610-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Lilli Anselm
Katrin Groebke Zbinden
Wolfgang Haap
Hans Hilpert
Jacques Himber
Bernd Kuhn
Narendra Panday
Fabienne Ricklin
Stefan Thomi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0618610A2 publication Critical patent/BRPI0618610A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0618610-6A 2005-11-16 2006-11-06 derivados de pirrolidina como inibidores de fator xa de coagulação BRPI0618610A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05110818 2005-11-16
EP05110818.1 2005-11-16
PCT/EP2006/068138 WO2007057317A1 (en) 2005-11-16 2006-11-06 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa

Publications (1)

Publication Number Publication Date
BRPI0618610A2 true BRPI0618610A2 (pt) 2011-09-06

Family

ID=37618744

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0618610-6A BRPI0618610A2 (pt) 2005-11-16 2006-11-06 derivados de pirrolidina como inibidores de fator xa de coagulação

Country Status (9)

Country Link
US (1) US7601752B2 (zh)
EP (1) EP1951717A1 (zh)
JP (1) JP2009515925A (zh)
KR (1) KR101020440B1 (zh)
CN (1) CN101309919A (zh)
AU (1) AU2006314637A1 (zh)
BR (1) BRPI0618610A2 (zh)
CA (1) CA2629080A1 (zh)
WO (1) WO2007057317A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550487B2 (en) * 2004-03-26 2009-06-23 Hoffmann-La Roche Inc. Pyrrolidine-3,4-dicarboxamide derivatives
UA93990C2 (ru) * 2005-10-11 2011-03-25 Интермюн, Инк. Соединения и способ ингибирования репликации вируса гепатита c
KR20090024834A (ko) * 2006-07-05 2009-03-09 인터뮨, 인크. C형 간염 바이러스 복제의 신규 억제제
CA2686138A1 (en) * 2007-05-03 2008-11-13 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis c virus replication
JP2010526789A (ja) * 2007-05-10 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー Fxaインヒビターの新規固形形態
MX2009012093A (es) 2007-05-10 2010-01-25 Intermune Inc Nuevos peptidos inhibidores de la replicacion del virus de la hepatitis c.
AU2009249443A1 (en) * 2008-04-15 2009-11-26 Intermune, Inc. Novel macrocyclic inhibitors of hepatitis C virus replication
AR075584A1 (es) * 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
EP2483290A4 (en) * 2009-09-28 2013-05-01 Intermune Inc CYCLIC PEPTIC INHIBITORS FOR REPLICATION OF HEPATITIS C VIRUS
CN104557930B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构凝血因子Xa抑制剂及其用途
CN104557929B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一类含二环酰胺结构的凝血因子Xa抑制剂及其用途
CN104725374B (zh) * 2015-02-14 2016-08-24 佛山市赛维斯医药科技有限公司 一种含双酰胺基和腈基苯结构的FXa抑制剂及其用途
CN104860942B (zh) * 2015-02-14 2016-08-24 佛山市赛维斯医药科技有限公司 一种含双酰胺基和硝基苯基结构的FXa抑制剂及其用途
CN104592227B (zh) * 2015-02-14 2016-06-01 佛山市赛维斯医药科技有限公司 一类含酰胺和卤代苯结构的FXa抑制剂、制备方法及其用途
CN104557928B (zh) * 2015-02-14 2016-08-24 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构凝血因子Xa抑制剂、其制备方法及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0910565A1 (en) 1997-02-14 1999-04-28 Bayer Corporation Amide derivatives as selective neuropeptide y receptor antagonists
CN1158258C (zh) 1999-06-24 2004-07-21 东丽株式会社 肾上腺素能α1B受体拮抗药
US6552016B1 (en) * 1999-10-14 2003-04-22 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto
CA2388468C (en) * 1999-10-14 2011-01-25 Curis, Inc. Mediators of hedgehog signalling pathways, compositions and uses related thereto
JP2004509104A (ja) * 2000-09-11 2004-03-25 ジェネンテック・インコーポレーテッド セリンプロテアーゼのアミジンインヒビター
JP4109890B2 (ja) * 2001-04-19 2008-07-02 田辺三菱製薬株式会社 医薬組成物
US20030114448A1 (en) 2001-05-31 2003-06-19 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
US7030141B2 (en) 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
JP4109288B2 (ja) 2002-12-25 2008-07-02 第一三共株式会社 ジアミン誘導体
JP2004210716A (ja) 2002-12-27 2004-07-29 Dai Ichi Seiyaku Co Ltd ジアミド誘導体
US7205318B2 (en) 2003-03-18 2007-04-17 Bristol-Myers Squibb Company Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
NZ543366A (en) 2003-04-03 2008-11-28 Merck Patent Gmbh Carbonyl compounds
DE10329457A1 (de) * 2003-04-03 2005-01-20 Merck Patent Gmbh Ethinylprolinderivate
AU2004226281B2 (en) 2003-04-03 2010-06-10 Merck Patent Gmbh Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
EP1633346B1 (de) 2003-06-18 2006-08-23 MERCK PATENT GmbH Pyrrolidin-1,2-dicarbonsäure-1-¬(4-ethinyl-phenyl)-amid|-2-¬(phenyl)-amid| derivate als inhibitoren der koagulationsfaktoren xa und viia zur behandlung von thrombosen
US20050119266A1 (en) 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
JPWO2005040172A1 (ja) * 2003-10-29 2007-03-08 協和醗酵工業株式会社 三環性プロリン誘導体
US7820699B2 (en) * 2005-04-27 2010-10-26 Hoffmann-La Roche Inc. Cyclic amines

Also Published As

Publication number Publication date
US20070112001A1 (en) 2007-05-17
CA2629080A1 (en) 2007-05-24
JP2009515925A (ja) 2009-04-16
CN101309919A (zh) 2008-11-19
KR20080059448A (ko) 2008-06-27
US7601752B2 (en) 2009-10-13
KR101020440B1 (ko) 2011-03-08
WO2007057317A1 (en) 2007-05-24
AU2006314637A1 (en) 2007-05-24
EP1951717A1 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
BRPI0618610A2 (pt) derivados de pirrolidina como inibidores de fator xa de coagulação
KR101083506B1 (ko) 신규한 헤테로아릴 융합된 환형 아민
KR101047211B1 (ko) 인자 xa 억제제로서의 신규 사이클로알케인카복스아마이드
JP4955009B2 (ja) 凝固因子Xaの阻害剤としての炭素環式縮合環アミン
BRPI0609917A2 (pt) aminas cìclicas
RU2375356C2 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОЛА В КАЧЕСТВЕ ИНГИБИТОРОВ TAFIa
BRPI0707802A2 (pt) compostos de prolinamidas substituÍdas, sais fisiologicamente compatÍveis e uso dos mesmos, medicamento e processo de produÇço do mesmo
AU2004279412A1 (en) Thioether-substituted benzamides as inhibitors of Factor Xa
KR20090053813A (ko) 응고 인자 IXa 억제제로 사용되는 타르트레이트 유도체
BRPI0509256B1 (pt) Derivados de pirrolidina-3,4-dicarboxamida que inibem o fator xa de coagulação
Koshio et al. Synthesis and biological activity of novel 1, 4-diazepane derivatives as factor Xa inhibitor with potent anticoagulant and antithrombotic activity
EP1409479A2 (en) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists
KR101124879B1 (ko) 신규 헤테로아릴 카복스아마이드

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2214 DE 11/06/2013.